Predictive value of left ventricular ejection fraction in stem cell transplantation

Bone Marrow Transplantation

Volumn 23, Issue 9, 1999, Pages 917-920

  Zangari, M ^a,b   Henzlova, M J ^a   Ahmad, S ^a   Scigliano, E ^a   Isola, L ^a   Platnik, J ^a   Croft, L B ^a   Sandler, D ^a   Diamond, J A ^a   Machac, J ^a   Fruchtman, S M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Ejection; Fraction; Transplantation

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; AUTOTRANSPLANTATION; EXERCISE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0032905589     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701734     Document Type: Article

References (14)

1. Stewart JR, Fajardo LF. Radiation-induced heart disease: an update. Prog Cardiovasc Dis 1984; 27: 173-194.
2. Taymor-Luria H, Cohn K, Pasternak RC. Diagnostic challenge: how to identify radiation heart disease. J Cardiovasc Med 1983; 8: 113-123.
3. Bristow MR, Billingham ME, Mason JW, Daniels JR. Clinical spectrum of anthracycline antibiotic cardiotoxicity. Cancer Treat Rep 1978; 62: 873-879.
4. Goldberg MA, Antin JH, Guinan EC, Rappeport JM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood 1986; 68: 1114-1118.
5. Steinherz LJ, Steinherz PG, Mangiacasale D et al. Cardiac changes with cyclophosphamide. Med Pediatr Oncol 1981; 9: 417-422.
6. Baello EB, Ensberg ME, Ferguson DW et al. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation. Cancer Treat Rep 1986; 70: 1187-1193.
7. Cazin B, Gorin NC, Laporte JP et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive patients. Cancer 1986; 57: 2061-2069.
8. Kupari M, Volin L, Suodas A et al. Cardiac involvement in bone marrow transplantation: electrocardiographic change arrhythmias, heart failure and autopsy findings. Bone Marrow Transplant 1990; 5: 91-98.
9. Gottdiener JS, Appelbaumer FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy. Arch Intern Med 1981; 141: 758-763.
10. Gardner SF, Lazarus HM, Bednarczyk EM et al. High-dose cyclophosphamide-induced myocardial damage during BMT: assessment by positron emission tomography. Bone Marrow Transplant 1993; 12: 139-144.
11. Bearman SI, Peterson FB, Schor RA et al. Radionuclide ejection fractions in evaluation of patients being considered for bone marrow transplantation. Bone Marrow Transplant 1990; 5: 173-177.
12. Hertenstein B, Stefanie M, Schmeiser T et al. Cardiac toxicity of bone marrow transplantation; predictive value of cardiologic evaluation before transplant. J Clin Oncol 1994: 12: 998-1004.
13. Fazio S, Pallmieri EA, Ferravante BF et al. Doxorubicin-induced cardiomyopathy treated with Carvedilol. Clin Cardiol 1998; 21: 777-779.
14. Shaddy RE, Olsen SL, Bristow MR et al. Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients. Am Heart J 1995; 129:197-199.